Literature DB >> 1505606

The effect of three different oral doses of verapamil on the disposition of theophylline.

K A Stringer1, J Mallet, M Clarke, J A Lindenfeld.   

Abstract

Results of previous studies suggest that the theophylline-verapamil drug interaction may be dependent on verapamil dose. Therefore, in a randomized four-way cross over study, 12 healthy males received theophylline, as a single intravenous dose of aminophylline, alone (phase I) and after a four day regimen of oral verapamil 40 mg (phase II), 80 mg (phase III), and 120 mg (phase IV) every 8 h. Serial blood samples were collected over a 24 hour period for determination of serum theophylline concentration and subsequent pharmacokinetic analysis. Mean theophylline AUC for phase I-IV was 93.6, 105.6, 110.8, 120.1 mg.h.l-1, respectively. Mean theophylline clearance for phase I-IV was 3.89, 3.59, 3.35, and 3.20 l.h-1, respectively. The changes in AUC, clearance, and lambda z were linearly correlated to verapamil dose. These results suggest that the inhibitory effect of verapamil on the pharmacokinetic disposition of theophylline is directly related to verapamil dose.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505606     DOI: 10.1007/bf02280751

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Effect of calcium channel blockers on theophylline disposition.

Authors:  S M Sirmans; J A Pieper; R L Lalonde; D G Smith; T H Self
Journal:  Clin Pharmacol Ther       Date:  1988-07       Impact factor: 6.875

2.  Increased serum theophylline concentrations secondary to oral verapamil.

Authors:  T G Burnakis; M Seldon; A D Czaplicki
Journal:  Clin Pharm       Date:  1983 Sep-Oct

3.  Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.

Authors:  R J Rodeheffer; J A Rommer; F Wigley; C R Smith
Journal:  N Engl J Med       Date:  1983-04-14       Impact factor: 91.245

4.  Selective inhibitory effects of nifedipine and verapamil on oxidative metabolism: effects on theophylline.

Authors:  R A Robson; J O Miners; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

5.  Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil.

Authors:  K W Renton
Journal:  Biochem Pharmacol       Date:  1985-07-15       Impact factor: 5.858

6.  Calcium and stimulus-secretion coupling in gastric fundic mucosa. Effect of inhibition of calcium transport by verapamil on gastric acid secretion in the isolated guinea pig fundic mucosa and in healthy subjects.

Authors:  P Kirkegaard; J Christiansen; B Petersen; P Skov Olsen
Journal:  Scand J Gastroenterol       Date:  1982-06       Impact factor: 2.423

Review 7.  Calcium antagonists in the management of asthma: breakthrough or ballyhoo?

Authors:  K L Massey; L Hendeles
Journal:  Drug Intell Clin Pharm       Date:  1987-06

8.  The effect of verapamil on the pharmacokinetic disposition of theophylline in cigarette smokers.

Authors:  A S Gin; K A Stringer; L S Welage; J H Wilton; G E Matthews
Journal:  J Clin Pharmacol       Date:  1989-08       Impact factor: 3.126

9.  Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.

Authors:  D R Abernethy; J M Egan; T H Dickinson; G Carrum
Journal:  J Pharmacol Exp Ther       Date:  1988-03       Impact factor: 4.030

Review 10.  Calcium-channel blocking agents for gastrointestinal disorders.

Authors:  D O Castell
Journal:  Am J Cardiol       Date:  1985-01-25       Impact factor: 2.778

View more
  7 in total

1.  A mechanistic approach for the scaling of clearance in children.

Authors:  Andrea N Edginton; Walter Schmitt; Barbara Voith; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Development and evaluation of a generic physiologically based pharmacokinetic model for children.

Authors:  Andrea N Edginton; Walter Schmitt; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 3.  Clinically significant pharmacokinetic interactions between dietary caffeine and medications.

Authors:  J A Carrillo; J Benitez
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

Review 4.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

5.  A physiologically based pharmacokinetic model to predict disposition of CYP2D6 and CYP1A2 metabolized drugs in pregnant women.

Authors:  Alice Ban Ke; Srikanth C Nallani; Ping Zhao; Amin Rostami-Hodjegan; Nina Isoherranen; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2013-01-25       Impact factor: 3.922

Review 6.  Clinical pharmacokinetics of vasodilators. Part I.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

7.  Volume of Distribution is Unaffected by Metabolic Drug-Drug Interactions.

Authors:  Jasleen K Sodhi; Caroline H Huang; Leslie Z Benet
Journal:  Clin Pharmacokinet       Date:  2021-02       Impact factor: 5.577

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.